Business Standard

Piramal Pharma lists at Rs 202 on BSE; shares tumble 5% intra-day

In October 2021, the board of directors of Piramal Enterprises (PEL) had approved the demerger of the pharmaceuticals business, and simplification of the corporate structure

Piramal Pharma
Premium

Photo: Twitter

SI Reporter Mumbai
Shares of Piramal Pharma (PPL) listed at Rs 201.80 on the BSE, and at Rs 200 on the National Stock Exchange (NSE) on Wednesday. The stock slipped to a low of Rs 191.75, down 5 per cent from its opening level, on the BSE. It's  inra-day low was Rs 191.35 on the NSE. A combined 1.8 million equity shares had changed hands on the NSE and BSE till 10:06 AM.

The equity shares of PPL have been listed and admitted to dealings on the exchange in the list of 'T' group of securities. In the T2T segment, each trade

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in